iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land
iRhythm Technologies shares dropped 7.5% to $156.24 Tuesday after the company announced 2026 sales targets and a restructuring plan during the J.P. Morgan Healthcare Conference. The company raised its 2025 revenue forecast above $740 million and projected 2026 revenue of $870–$880 million. iRhythm also created a new holding-company structure, effective Jan. 12, with no change to its ticker symbol.